ArticleFrontiers in pharmacology2022

Effect of theaflavin-3,3'-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota.

Cheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.